HSP90 Inhibitors Central
A site dedicated to the cancer drug class targeting Heat Shock Protein 90 (HSP90). Featuring drug discovery, clinical development, business transaction, conference presentations, etc related to these drugs including ganetespib, AT13387, retaspimycin, 17-AAG and more.
HSP90 Inhibitors Central's Latest Posts
Recent highlights from the scientific literature related to a few of my favorite oncology clinical targets: PI3K, HSP90, and ALK... The Structural Basis of PI3K Cancer Mutations: From Mechanism to Therapy.Liu S [...]
Log in to leave a comment